Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-02-09
1998-12-08
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462794, 523100, 524102, A01N 4340
Patent
active
058469834
ABSTRACT:
A method is provided to treat inflammatory bowel disease by locally administering to the colon an effective amount of nicotine or a pharmaceutically acceptable salt thereof, preferably via formulations adapted for delayed oral release or rectal administration. Further provided is a novel formulation for the oral administration of nicotine comprising a polyacrylic polymer complexed with nicotine.
REFERENCES:
patent: 4855142 (1989-08-01), Fankhauser et al.
patent: 5604231 (1997-02-01), Smith et al.
Thomas, G. A. O., et al, Eur. J. Gastroenterol, 8, 769-776 (1996).
Lichtiger S., et al, N. Engl. J. Med. 330, No. 26, 1841-1845 (Jun. 30, 1994).
Sandborn, W. J., et al, Gastroenterology, 108, 1429-1435 (1994).
Thomas, G. A. O., et al, N. Engl. J. Med., 332, No. 15, 988-992 (Apr. 19, 1995).
Lichtiger, S., et al, Gastroenterology, vol. 104, No. 4, Part 2, p. A732 AGA Abstracts (Apr. 1993).
Zins, B. J., et al, Gastroenterology, vol. 110, No. 4, p. A1054 (Apr. 1996).
Cecil Textbook of Medicine, 19th edition, edited by Wyngaarden, J.B. et al, W.B. Saunders Co., pp. 699-708, Oct. 1992.
Handbook of Pharmaceutical Excipients, 2nd edition, 363.
Danish Budesinode Study Group, Scand J. Gastroent., 1991, 26, pp. 1225-1230.
Winter, T.A. et al, Scand. J. Gastroent., 1993, 28(8), pp. 701-704, abstract only.
"Noncompartmental Analysis Based on Statistical Momemt Theory", Pharmacokinetics, 2nd ed., M. Gibaldi (ed), Marcel Dekker Inc., New York, pp. 409-417, (1982).
"Rectal Topical Corticosteroid Preparations", Drug and Therapeutics Bulletin, 29, Publ. Consumer' Association, London, pp. 66-68, (1991).
N. L. Benowitz, et al., "Stable Isotope Studies of Nicotine Kinetics and Bioavailability", Clin. Pharmacol. Ther., 49, 270-277, (1991).
M. H. Brock, et al., "Use of In Vitro and In Vivo Data in the Design, Development, and Quality Control of Sustained-Release Decongestant Dosage Forms", Pharmacotherapy, 14, 430-437, (1994).
P. Dominiak, et al., "Effects of nicotine and its major metabolites on blood pressure in anesthetized rate", Klin. Wochenschr., 63, 90-92 (1985),.
M. J. Durrani, et al., "Studies on Drug Release Kinetics from Carbopol 934P Tablets", Pharmaceutical Res. (Suppl.), 8, S-135, (1991).
S. Edsbacker, et al., "Pharmacokinetics and Gastrointestinal Transit of Budesonide Controlled Ileal Release (CIR) Capsules", Gastroenterology (Supp), 104, A695, (Apr. 1993).
D. F. Glenn, et al., "Synthesis and Mass Spectrometry of Some Structurally Related Nicotinoids", J. Org. Chem., 43, 2860-70, (1978).
G. R. Greenberg, et al., "Oral Budesonide for Active Crohn's Disease", NEJM, 331, 836-41, (1994).
D. A. Hutton, et al., "Mucolysis of the Colonic Mucus Barrier By Faecal Proteinases: Inhibition by Interacting Polyacrylate", Clin. Sci. 78, 265-271, (1990).
L. G. Miller, et al., "Reversible Alterations in Immunoregulatory T Cells in Smoking", Chest, 82, No. 5, 526-529, (1982).
R. D. Pullan, et al., "Comparison of Bismuth Citrate and 5-aminosalicylic Acid Enemas in Distal Ulcerative Colitis: A Controlled Trial", Gut, 34, 676-679, (1993).
R. D. Pullan, et al., "Transdermal Nicotine for Active Ulcerative Colitis", NEJM, 330, No. 12, 811-815, (Mar. 24, 1994).
C. J. Roberts, et al., "Non-smoking: A Feature of Ulcerative Colitis", Br. Med. J., 285, 440, (1982).
W. J. Sandborn, et al., "The Pharmokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration", J. Clin. Pharmacol., 31, 76-80, (1991).
K. W. Schroeder, et al., "Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis", NEJM, 317, 1625-29, (1987).
E. D. Srivastava, et al., "Transdermal Nicotine in Active Ulcerative Colitis", Eur. J. Gastro. & Hepat., 3, 815-818, (1991).
L. R. Sutherland, "Topical Treatment of Ulcerative Colitis", Medical Clinics of North America, 74, 119-131, (1990).
G. A. O. Thomas, "Nicotine Therapy for Ulcerative Colitis", Dissertation for the degree of Doctor of Medicine, London University, (Jul. 1995).
Rhodes John
Sandborn William J.
Dahlen Garth
Kight John
Mayo Foundation for Medical Education and Research
LandOfFree
Colonic delivery of nicotine to treat inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Colonic delivery of nicotine to treat inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colonic delivery of nicotine to treat inflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177542